Net Loss Per Share

12 Months Ended

Dec. 31, 2021

Earnings Per Share [Abstract]

Net Loss Per Share

NET LOSS PER SHARE

Basic and diluted net loss per share have been computed by dividing the net loss by the weighted-average number of common shares outstanding during the period, without consideration of common share equivalents as their effect would have been antidilutive.

For the years ended December 31, 2021, 2020 and 2019, all common share equivalents have been excluded from the calculation of diluted net loss per share, as their effect would be antidilutive.

The following tables set forth the computation of the Company’s basic and diluted net loss per share (in thousands, except shares and per share data):

	Year Ended December 31,
	2021		2020		2019
Numerator:
Net loss used to compute basic net loss per share	$	(30,662)	$	(18,714)	$	(21,968)
Net loss used to compute diluted net loss per share	$	(30,662)	$	(18,714)	$	(21,968)
Denominator:
Weighted-average shares used to compute basic net loss per share	52,241,076		46,481,772		42,151,617
Weighted-average shares used to compute diluted net loss per share	52,241,076		46,481,772		42,151,617
Net loss per share:
Basic	$	(0.59)	$	(0.40)	$	(0.52)
Diluted	$	(0.59)	$	(0.40)	$	(0.52)

The following potentially dilutive securities have been excluded from diluted net loss per share because their effect would be antidilutive:

	Year Ended December 31,
	2021	2020	2019
Shares of common stock subject to outstanding options	1,863,633	2,670,398	2,609,848
Shares of common stock subject to outstanding common stock warrants	3,132	6,264	355,240
Shares of common stock subject to contingent consideration	—	—	10
Restricted stock units	2,047,657	1,878,866	1,516,285
Total common stock equivalents	3,914,422	4,555,528	4,481,383

During April 2020, the Company issued and sold 1,000,000 shares of its common stock under the Sales Agreement pursuant to an “at-the-market” equity offering.

On June 15, 2020, the Company completed an underwritten public offering pursuant to which the Company sold 4,492,187 shares of common stock.

On January 25, 2021 and February 11, 2021, the Company completed an underwritten public offering, including the sale of shares pursuant to the exercise of the underwriters' over-allotment option, pursuant to which the Company sold 1,923,077 and 288,461 shares of common stock, respectively.